Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 618.00p on 19-03-2026 at 19:25:07
Change -26.00p -4.04%
Buy 625.00p
Sell 622.00p
Last Trade: Sell 194.00 at 618.00p
Day's Volume: 246,841
Last Close: 618.00p
Open: 630.00p
ISIN: GB00BDFBVT43
Day's Range 618.00p - 638.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £746.99m
VWAP: 626.4344p
Shares in Issue: 120.87m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 194 618.00p SI Trade
Suspected SELL Trade
16:48:29 - 19-Mar-26
Sell* 802 618.00p SI Trade
16:35:21 - 19-Mar-26
Sell* 76 618.00p SI Trade
16:35:21 - 19-Mar-26
Sell* 64,058 618.00p Uncrossing Trade
16:35:21 - 19-Mar-26
Buy* 233 624.00p Automatic Execution
16:29:36 - 19-Mar-26
Buy* 123 624.00p Automatic Execution
16:29:36 - 19-Mar-26
Sell* 78 623.00p Automatic Execution
16:29:36 - 19-Mar-26
Sell* 28 623.00p Automatic Execution
16:29:36 - 19-Mar-26
Sell* 142 623.00p Automatic Execution
16:29:36 - 19-Mar-26
Sell* 65 624.00p Automatic Execution
16:28:28 - 19-Mar-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
19th Mar 2026 (Thu) 630.00 638.00 618.00 618.00 246,841
18th Mar 2026 (Wed) 630.00 661.00 630.00 644.00 538,383
17th Mar 2026 (Tue) 650.00 650.00 625.00 637.00 243,628
16th Mar 2026 (Mon) 642.00 642.00 625.00 633.00 93,494
13th Mar 2026 (Fri) 630.00 638.00 622.00 630.00 104,796
12th Mar 2026 (Thu) 630.00 641.00 625.00 631.00 164,565
11th Mar 2026 (Wed) 672.00 672.00 630.00 637.00 138,514
10th Mar 2026 (Tue) 591.00 651.00 591.00 651.00 202,230
9th Mar 2026 (Mon) 610.00 615.00 592.00 615.00 259,659
6th Mar 2026 (Fri) 669.00 669.00 614.00 624.00 206,795
5th Mar 2026 (Thu) 656.00 659.00 637.00 638.00 127,926
4th Mar 2026 (Wed) 635.00 659.00 617.00 659.00 285,432
3rd Mar 2026 (Tue) 670.00 670.00 616.00 626.00 373,910
2nd Mar 2026 (Mon) 662.00 662.00 630.00 645.00 329,716
27th Feb 2026 (Fri) 631.00 663.00 629.00 663.00 1,067,990
26th Feb 2026 (Thu) 627.00 632.00 599.00 621.00 647,572
25th Feb 2026 (Wed) 680.00 684.00 618.00 632.00 2,068,914
24th Feb 2026 (Tue) 757.00 757.00 667.00 683.00 1,118,844
23rd Feb 2026 (Mon) 783.00 791.00 765.00 774.00 689,300
20th Feb 2026 (Fri) 789.00 795.00 782.00 792.00 161,216
19th Feb 2026 (Thu) 780.00 805.00 780.00 790.00 144,309
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
18th Mar 2026 7:00 am RNS-R Licensing agreement with VVMF
9th Mar 2026 7:53 am RNS Admission to Trading
4th Mar 2026 11:45 am RNS Admission to Trading Application
3rd Mar 2026 7:00 am RNS Capital Markets Day and investor conferences
2nd Mar 2026 7:00 am RNS Total Voting Rights
27th Feb 2026 1:31 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
26th Feb 2026 1:49 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 12:33 pm RNS Form 8.3 - Oxford Biomedica plc
26th Feb 2026 11:09 am RNS Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

UK earnings, trading statements calendar - next 7 days

19th Mar 2026 14:38

Read More

IN BRIEF: Oxford Biomedica inks new licensing and option deal

18th Mar 2026 12:22

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Enters a five-year licensing and option agreement with Viral Vector Manufacturing Facility, an Australian contract development and manufacturing organisation (CDMO) and "the country's first commercial manufacturing facility of its kind", having signed a non-binding terms sheet in October. VVMF will have a non-exclusive global licence to use Oxford BioMedica's inAAVate platform "know-how and intellectual property", and an option to extend the licence to the LentiVector platform. OXB says it will receive a low single-digit million licence fee and is eligible for future platform use payments. Expects the contract to enable VVMF "to accelerate its operational and commercial readiness to provide advanced viral vector technologies to customers, capturing global demand with a particular focus on the fast-growing APAC region, and positioning Australia as a regional hub for high‑quality cell and gene therapy manufacturing." Read More

EQT abandons Oxford BioMedica takeover bid after proposals rejected

25th Feb 2026 16:02

(Alliance News) - EQT Fund Management SARL confirmed on Wednesday it has no intention of making an offer for Oxford BioMedica PLC. Read More

Oxford BioMedica revenue climbs 30% in 2025 as backlog grows

24th Feb 2026 09:48

(Alliance News) - Oxford BioMedica PLC on Tuesday said it expects to report revenue at the upper end of guidance as contracted orders increased. Read More

Oxford BioMedica expands cancer therapy deal with Bristol-Myers Squibb

4th Feb 2026 11:57

(Alliance News) - Oxford BioMedica PLC on Wednesday said it has signed a new commercial supply deal with Bristol-Myers Squibb Co. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,063.50
Change-241.79

Login to your account

Forgot Password?

Not Registered